CP Pharmaceuticals Limited FDA Record
- Latest inspection OAI · Oct 13, 2015
- Last warning letter 2016
CP Pharmaceuticals Limited has 0 FDA recalls, 4 inspections, 0 510(k) clearances and 2 compliance actions on record. FDA has issued 2 warning letters to CP Pharmaceuticals Limited, the most recent on Nov 16, 2016.
- Latest inspection
- Oct 13, 2015 · OAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 4 | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 2 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Reviewing CP Pharmaceuticals Limited as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check CP Pharmaceuticals Limited yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
CP Pharmaceuticals Limited FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Nov 16, 2016 · Record page | |||
| Oct 29, 2010 · Record page |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Oct 13, 2015 | Wrexham, United Kingdom | Drugs | Official Action Indicated (OAI) | 3003369660 |
| Sep 10, 2013 | Wrexham, United Kingdom | Drugs | Voluntary Action Indicated (VAI) | 3003369660 |
| May 13, 2011 | Wrexham, United Kingdom | Drugs | Voluntary Action Indicated (VAI) | 3003369660 |
| Jul 29, 2010 | Wrexham, United Kingdom | Drugs | Official Action Indicated (OAI) | 3003369660 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 2 compliance actions under CP Pharmaceuticals Limited: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3003369660 | Wrexham, United Kingdom | 4 | Oct 13, 2015 |
CP Pharmaceuticals Limited and the FDA: common questions
Has CP Pharmaceuticals Limited received an FDA warning letter?
Yes. FDA has issued 2 warning letters to CP Pharmaceuticals Limited. The most recent is dated Nov 16, 2016.
Has CP Pharmaceuticals Limited received an FDA Form 483?
FDA has not published a Form 483 for "CP Pharmaceuticals Limited" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect CP Pharmaceuticals Limited?
The most recent FDA inspection on file ended Oct 13, 2015 at Wrexham, United Kingdom and was classified OAI. FDA has 4 inspections of CP Pharmaceuticals Limited on file, 2 of them classified OAI (official action indicated).
Need more than this page shows? Ask about CP Pharmaceuticals Limited in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.